Clicky

Mayne Pharma Group Ltd  (MYX)

Description: Mayne Pharma Group Limited is a specialty pharmaceutical company, which focuses on applying its drug delivery capability to commercialize branded and generic pharmaceuticals. The Company also provides contract development and manufacturing services. It operates in four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.


Keywords: Pharmaceutical Pharmaceutical Products Contract Manufacturing Contract Manufacturing Services Drug Delivery Manufacturing Services Contract Services Generic Drug Generic Pharmaceuticals Pharmaceutical Development Generic Pharmaceutical Products Contract Development Alembic Pharmaceuticals Ltd Ajanta Pharma Generic Pharmaceutical Product

Home Page: www.maynepharma.com

MYX Technical Analysis

1538 Main North Road
Salisbury South, SA 5106
Australia
Phone: 61 8 8209 2666


Officers

Name Title
Mr. Shawn Patrick O'Brien B.Sc CEO, MD & Director
Mr. Aaron Gray Chief Financial Officer
Ms. Lisa Pendlebury VP of Investor Relations & Communications
Ms. Kimberly Parker J.D. Exec. VP & Gen. Counsel
Mr. Brant Schofield Exec. VP of Corp. Devel.
Dr. Andrew O. Herdman Ph.D. VP of Group HR
Mr. Stefan J. Cross Pres of International Operations
Mr. Daniel Moore Exec. VP of Specialty Products & Patient Solutions
Mr. Gerard G. Nahum M.D. Chief Medical Officer
Mr. Hemanshu N. Pandya Sr. VP & Head of Generic Product Division

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 285.7143
Trailing PE: 0
Price-to-Book MRQ: 0.6161
Price-to-Sales TTM: 0.8396
IPO Date: 2007-06-29
Fiscal Year End: June
Full Time Employees: 0
Back to stocks